The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Diamino-5-isopropyl-6-(2'-naphthylsulfanyl)-7H-pyrrolo[2,3-d]pyrimidine ID: ALA477150
PubChem CID: 24950853
Max Phase: Preclinical
Molecular Formula: C19H19N5S
Molecular Weight: 349.46
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)c1c(Sc2ccc3ccccc3c2)[nH]c2nc(N)nc(N)c12
Standard InChI: InChI=1S/C19H19N5S/c1-10(2)14-15-16(20)22-19(21)24-17(15)23-18(14)25-13-8-7-11-5-3-4-6-12(11)9-13/h3-10H,1-2H3,(H5,20,21,22,23,24)
Standard InChI Key: FVTLWDMKFHXFCR-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
3.6819 -12.8583 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6807 -13.6857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3956 -14.0985 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3938 -12.4455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1091 -12.8547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1094 -13.6857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8999 -13.9423 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3882 -13.2698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8982 -12.5991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9660 -14.0976 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3913 -11.6205 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2097 -13.2658 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.6122 -13.9860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1868 -14.6933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5886 -15.4129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4325 -13.9945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2651 -11.8581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8079 -11.1714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0884 -11.8054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8368 -14.7112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4149 -15.4200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8155 -16.1358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6397 -16.1490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0615 -15.4402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6593 -14.7182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8 12 1 0
2 3 1 0
12 13 1 0
3 6 2 0
13 14 2 0
1 2 2 0
14 15 1 0
15 21 2 0
5 4 2 0
20 16 2 0
16 13 1 0
6 7 1 0
9 17 1 0
7 8 1 0
17 18 1 0
8 9 2 0
17 19 1 0
20 21 1 0
9 5 1 0
4 1 1 0
2 10 1 0
5 6 1 0
4 11 1 0
20 25 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 349.46Molecular Weight (Monoisotopic): 349.1361AlogP: 4.55#Rotatable Bonds: 3Polar Surface Area: 93.61Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.13CX Basic pKa: 8.33CX LogP: 4.64CX LogD: 3.69Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.50Np Likeness Score: -0.53
References 1. Gangjee A, Jain HD, Queener SF, Kisliuk RL.. (2008) The effect of 5-alkyl modification on the biological activity of pyrrolo[2,3-d]pyrimidine containing classical and nonclassical antifolates as inhibitors of dihydrofolate reductase and as antitumor and/or antiopportunistic infection agents., 51 (15): [PMID:18605720 ] [10.1021/jm800244v ]